Stoke Therapeutics
STOK
#5004
Rank
C$2.51 B
Marketcap
C$38.45
Share price
-0.45%
Change (1 day)
-7.07%
Change (1 year)

Earnings for Stoke Therapeutics (STOK)

Earnings in 2026 (TTM): -C$0.35 Billion

According to Stoke Therapeutics's latest financial reports the company's current earnings are C$28.21 Million. In 2025 the company made an earning of -C$9.88 Million, an increase over its 2024 earnings that were of -C$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Stoke Therapeutics from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.35 Billion3355.85%
2025 -C$9.88 Million-92.26%
2024 -C$0.13 Billion-15.01%
2023 -C$0.16 Billion3.59%
2022 -C$0.15 Billion17.79%
2021 -C$0.13 Billion64.24%
2020 -C$74.93 Million61.62%
2019 -C$46.36 Million158.17%
2018 -C$17.96 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-C$0.23 Billion-35.80%๐Ÿ‡บ๐Ÿ‡ธ USA